Toggle navigation
Home
Search
Services
Blog
Contact
About
Design/Synthesis of Oral Galanin Agonists/Antagonists
Manfred, Wolff
Immunopharmaceutics, Inc., San Diego, CA, United States
Search 3 grants from Wolff Manfred
Search grants from Immunopharmaceutics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Glucose and Amino Acid Catabolism in Plasma Cell Biology
NanoMedex Propofol Microemulsion (Microfol): Preclinical Studies to FDA IND App.
Decision-Making Under Uncertainty in Prostate Cancer
Translational Control of Transcription Termination
Inducible Responses of Cells to DNA Damage
Recently added grants:
High-dimensional variable selection and prediction of ordinal pathological response data
SCH: ChangeGradients: Promoting Adolescent Health Behavior Change with Clinically Integrated Sample-Efficient Policy Gradient Methods
Cannabinoid receptor control of a DRN to VTA pathway and its role in affective states
Inhibiting P13K p110B to block cocaine-induced habits and drug seeking
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43MH030021-002
Application #
3667508
Study Section
Project Start
1993-09-01
Project End
1994-04-15
Budget Start
1994-03-01
Budget End
1994-04-15
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Immunopharmaceutics, Inc.
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92127
Related projects
NIH 1994
N43 MH
Design/Synthesis of Oral Galanin Agonists/Antagonists
Manfred, Wolff / Immunopharmaceutics, Inc.
NIH 1993
N43 MH
Design/Synthesis of Oral Galanin Agonists/Antagonists
Wolff, Manfred E. / Immunopharmaceutics, Inc.
Comments
Be the first to comment on Wolff Manfred's grant